201 related articles for article (PubMed ID: 17671832)
1. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations.
Pearton M; Allender C; Brain K; Anstey A; Gateley C; Wilke N; Morrissey A; Birchall J
Pharm Res; 2008 Feb; 25(2):407-16. PubMed ID: 17671832
[TBL] [Abstract][Full Text] [Related]
2. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles.
Coulman SA; Barrow D; Anstey A; Gateley C; Morrissey A; Wilke N; Allender C; Brain K; Birchall JC
Curr Drug Deliv; 2006 Jan; 3(1):65-75. PubMed ID: 16472095
[TBL] [Abstract][Full Text] [Related]
3. Microfabricated silicon microneedles for nonviral cutaneous gene delivery.
Chabri F; Bouris K; Jones T; Barrow D; Hann A; Allender C; Brain K; Birchall J
Br J Dermatol; 2004 May; 150(5):869-77. PubMed ID: 15149498
[TBL] [Abstract][Full Text] [Related]
4. Hydrodynamic gene delivery in human skin using a hollow microneedle device.
Dul M; Stefanidou M; Porta P; Serve J; O'Mahony C; Malissen B; Henri S; Levin Y; Kochba E; Wong FS; Dayan C; Coulman SA; Birchall JC
J Control Release; 2017 Nov; 265():120-131. PubMed ID: 28254630
[TBL] [Abstract][Full Text] [Related]
5. Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression.
Pearton M; Saller V; Coulman SA; Gateley C; Anstey AV; Zarnitsyn V; Birchall JC
J Control Release; 2012 Jun; 160(3):561-9. PubMed ID: 22516089
[TBL] [Abstract][Full Text] [Related]
6. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
Sivaraman A; Banga AK
Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
[TBL] [Abstract][Full Text] [Related]
7. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin.
Kim M; Jung B; Park JH
Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788
[TBL] [Abstract][Full Text] [Related]
8. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy.
Coulman S; Allender C; Birchall J
Crit Rev Ther Drug Carrier Syst; 2006; 23(3):205-58. PubMed ID: 17206925
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles.
Birchall J; Coulman S; Pearton M; Allender C; Brain K; Anstey A; Gateley C; Wilke N; Morrissey A
J Drug Target; 2005 Aug; 13(7):415-21. PubMed ID: 16308210
[TBL] [Abstract][Full Text] [Related]
10. Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate.
Puri A; Nguyen HX; Banga AK
Int J Cosmet Sci; 2016 Oct; 38(5):512-23. PubMed ID: 27009797
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo evaluation of a microneedle array device for transdermal application.
Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
[TBL] [Abstract][Full Text] [Related]
12. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration.
Sivamani RK; Stoeber B; Wu GC; Zhai H; Liepmann D; Maibach H
Skin Res Technol; 2005 May; 11(2):152-6. PubMed ID: 15807814
[TBL] [Abstract][Full Text] [Related]
13. Microneedles: bench to bedside.
Kolli CS
Ther Deliv; 2015; 6(9):1081-8. PubMed ID: 26419290
[TBL] [Abstract][Full Text] [Related]
14. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety.
Donnelly RF; Singh TR; Alkilani AZ; McCrudden MT; O'Neill S; O'Mahony C; Armstrong K; McLoone N; Kole P; Woolfson AD
Int J Pharm; 2013 Jul; 451(1-2):76-91. PubMed ID: 23644043
[TBL] [Abstract][Full Text] [Related]
15. Enhanced skin delivery of vismodegib by microneedle treatment.
Nguyen HX; Banga AK
Drug Deliv Transl Res; 2015 Aug; 5(4):407-23. PubMed ID: 26069156
[TBL] [Abstract][Full Text] [Related]
16. Microneedle penetration and injection past the stratum corneum in humans.
Sivamani RK; Stoeber B; Liepmann D; Maibach HI
J Dermatolog Treat; 2009; 20(3):156-9. PubMed ID: 19016065
[TBL] [Abstract][Full Text] [Related]
17. Hydrogel Microneedles with Programmed Mesophase Transitions for Controlled Drug Delivery.
Dawud H; Edelstein-Pardo N; Mulamukkil K; Amir RJ; Abu Ammar A
ACS Appl Bio Mater; 2024 Mar; 7(3):1682-1693. PubMed ID: 38335540
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the in vitro penetration of quercetin through pig skin by combined microneedles and lipid microparticles.
Paleco R; Vučen SR; Crean AM; Moore A; Scalia S
Int J Pharm; 2014 Sep; 472(1-2):206-13. PubMed ID: 24928134
[TBL] [Abstract][Full Text] [Related]
19. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
Li G; Badkar A; Nema S; Kolli CS; Banga AK
Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
[TBL] [Abstract][Full Text] [Related]
20. Microneedle mediated delivery of nanoparticles into human skin.
Coulman SA; Anstey A; Gateley C; Morrissey A; McLoughlin P; Allender C; Birchall JC
Int J Pharm; 2009 Jan; 366(1-2):190-200. PubMed ID: 18812218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
